Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology
company, today announces the launch of its TOTAL ANKLE
Patient-Matched Guides, giving surgeons a predictable and efficient
option to help plan and perform total ankle replacement (TAR)
procedures. Engineered using 3D Systems’ VSP® surgical planning
workflows, all-in-one TOTAL ANKLE Patient-Matched Guides are
designed to achieve a precise patient fit using fluoroscopic
alignment cues and efficient instrumentation, and provide accuracy
to plan.1-8
Total ankle replacements are historically uncommon, preferring
non-surgical techniques or arthrodesis due to the complexity of the
procedure that results from differing patient anatomies. However,
the global market trajectory (CAGR of 6.98% through 2031)9 is being
bolstered by the rising prevalence of osteoarthritis in adults and
influenced by growing patient preference for joint preservation and
restoration.
Smith+Nephew’s TOTAL ANKLE Patient-Matched Guides are poised to
support the growing TAR market segment due to three key
benefits:
- Predictability in the OR: Integrated
fluoroscopic cues, guide pins, and cut slot make the guide an
all-in-one instrument.
- Accuracy: Fluoroscopic alignment cues and
standard instrumentation transfer pins are designed to provide
accuracy to plan.3,6.10,11
- User Friendly System: Guide is designed to
provide tactile feedback with medial arm wrap and precise patient
fit.1,2,12,13
Smith+Nephew partnered with South Carolina-based 3D Systems to
help design and manufacture the TOTAL ANKLE Patient-Matched Guides.
With more than 25 years of experience and FDA-cleared VSP surgical
planning workflows, the company’s solutions have supported more
than 175,000 patient-specific cases with the goal of improving
outcomes and the overall patient experience.
TOTAL ANKLE Patient-Matched Guides are compatible with chamfer
talar implants for Smith+Nephew’s CADENCE◊ Total Ankle System and
SALTO TALARIS◊ Total Ankle Prosthesis, offering surgeons
versatility of implant choice for their patients.
“We are excited to unveil our new TOTAL ANKLE Patient-Matched
Guides for total ankle replacement - a breakthrough to help
transform the way healthcare professionals approach surgical
precision and improved patient outcomes”, said Mark McMahan, Vice
President of Marketing, Global Trauma & Extremities at
Smith+Nephew. This advanced system is designed to offer
unparalleled efficiency and accuracy, ultimately enhancing the
overall experience for both surgeons and patients. The launch of
our TOTAL ANKLE Patient-Matched Guides further strengthens our
position as a leader in the total ankle replacement market
segment.”
To learn more about Smith+Nephew’s TOTAL ANKLE Patient-Matched
Guides, CADENCE Total Ankle System and SALTO TALARIS Total Ankle
Prosthesis, please visit the Total Ankle Patient-Matched
Guides Webpage or visit the Smith+Nephew booth (#115) at the
American Orthopaedic Foot & Ankle Society (AOFAS) Annual
Meeting from September 11-14 in Vancouver, British Columbia,
Canada.
- ends –
Media Enquiries Dave Snyder
+1 (978)
749-1440 Smith+Nephew
david.snyder@smith-nephew.com
References
- 3D Systems. Salto Ankle PSI System Design Validation Report.
RPT-1059
- 3D Systems. Cadence Ankle PSI System Design Validation Report.
RPT-1102
- 3D Systems. Salto Talaris PSI Operative Technique.
DCD-00360
- 3D Systems. Salto Talaris PSI Case Report Template.
DCD-00361
- 3D Systems. Cadence PSI Operative Technique. DCD-00359
- 3D Systems. Cadence PSI Case Report Template. DCD-00388
- 3D Systems. Salto Ankle PSI Virtual Planning Work Instruction.
WI-01098
- 3D Systems. Cadence Ankle PSI Virtual Planning Work
Instruction. WI-01184
- Global Total Ankle Replacement Market – Industry Trends and
Forecast to 2031. Data Bridge Market Research Report, June
2024
- 3D Systems. Salto Talaris PSI Talus Guide Drawing .
SPEC-0526
- 3D Systems. Cadence PSI Talus Guide Drawing . SPEC-0577
- 3D Systems. Salto Talaris PSI Tibia Guide Drawing.
SPEC-0525
- 3D Systems. Cadence PSI Tibia Guide Drawing. SPEC-0579 show
less
About Smith+Nephew
Smith+Nephew is a portfolio medical technology business focused
on the repair, regeneration and replacement of soft and hard
tissue. We exist to restore people’s bodies and their self-belief
by using technology to take the limits off living. We call this
purpose ‘Life Unlimited’. Our 18,000 employees deliver this mission
every day, making a difference to patients’ lives through the
excellence of our product portfolio, and the invention and
application of new technologies across our three global
business units of Orthopaedics, Sports Medicine & ENT and
Advanced Wound Management.
Founded in Hull, UK, in 1856, we now operate in more than 100
countries, and generated annual sales of $5.5 billion in 2023.
Smith+Nephew is a constituent of the FTSE100 (LSE:SN, NYSE:SNN).
The terms ‘Group’ and ‘Smith+Nephew’ are used to refer to Smith
& Nephew plc and its consolidated subsidiaries, unless the
context requires otherwise.
For more information about Smith+Nephew, please visit
www.smith-nephew.com and follow us on X, LinkedIn, Instagram
or Facebook.
About 3D Systems
More than 35 years ago, 3D Systems brought the innovation of 3D
printing to the manufacturing industry. Today, as the leading
additive manufacturing solutions partner, we bring innovation,
performance, and reliability to every interaction - empowering our
customers to create products and business models never before
possible. Thanks to our unique offering of hardware, software,
materials, and services, each application-specific solution is
powered by the expertise of our application engineers who
collaborate with customers to transform how they deliver their
products and services. 3D Systems’ solutions address a variety of
advanced applications in healthcare and industrial markets such as
medical and dental, aerospace & defense, automotive, and
durable goods. More information on the company is available at
www.3dsystems.com.
Forward-looking Statements
This document may contain forward-looking statements that may or
may not prove accurate. For example, statements regarding expected
revenue growth and trading profit margins, market trends and our
product pipeline are forward-looking statements. Phrases such as
"aim", "plan", "intend", "anticipate", "well-placed", "believe",
"estimate", "expect", "target", "consider" and similar expressions
are generally intended to identify forward-looking statements.
Forward-looking statements involve known and unknown risks,
uncertainties and other important factors that could cause actual
results to differ materially from what is expressed or implied by
the statements. For Smith+Nephew, these factors include: conflicts
in Europe and the Middle East, economic and financial conditions in
the markets we serve, especially those affecting healthcare
providers, payers and customers; price levels for established and
innovative medical devices; developments in medical technology;
regulatory approvals, reimbursement decisions or other government
actions; product defects or recalls or other problems with quality
management systems or failure to comply with related regulations;
litigation relating to patent or other claims; legal and financial
compliance risks and related investigative, remedial or enforcement
actions; disruption to our supply chain or operations or those of
our suppliers; competition for qualified personnel; strategic
actions, including acquisitions and disposals, our success in
performing due diligence, valuing and integrating acquired
businesses; disruption that may result from transactions or other
changes we make in our business plans or organisation to adapt to
market developments; relationships with healthcare professionals;
reliance on information technology and cybersecurity; disruptions
due to natural disasters, weather and climate change related
events; changes in customer and other stakeholder sustainability
expectations; changes in taxation regulations; effects of foreign
exchange volatility; and numerous other matters that affect us or
our markets, including those of a political, economic, business,
competitive or reputational nature. Please refer to the documents
that Smith+Nephew has filed with the U.S. Securities and Exchange
Commission under the U.S. Securities Exchange Act of 1934, as
amended, including Smith+Nephew's most recent annual report on Form
20-F, which is available on the SEC’s website at www. sec.gov, for
a discussion of certain of these factors. Any forward-looking
statement is based on information available to Smith+Nephew as of
the date of the statement. All written or oral forward-looking
statements attributable to Smith+Nephew are qualified by this
caution. Smith+Nephew does not undertake any obligation to update
or revise any forward-looking statement to reflect any change in
circumstances or in Smith+Nephew's expectations.
◊ Trademark of Smith+Nephew. Certain marks registered in US
Patent and Trademark Office.
Smith and Nephew (NYSE:SNN)
Historical Stock Chart
Von Okt 2024 bis Nov 2024
Smith and Nephew (NYSE:SNN)
Historical Stock Chart
Von Nov 2023 bis Nov 2024
